Enclave Advisors LLC Abbott Laboratories Transaction History
Enclave Advisors LLC
- $590 Billion
- Q3 2024
A detailed history of Enclave Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Enclave Advisors LLC holds 2,876 shares of ABT stock, worth $321,910. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,876Holding current value
$321,910% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,187Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$18.8 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.59 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.36 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$5.97 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $196B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...